Effectiveness analysis of levofloxacin and ceftriaxon antibiotics in pneumonia patients in the inpatient installation at RSD X Cirebon City Year 2023
Article Sidebar
Main Article Content
Page: 564-570
Abstract
Pneumonia is inflammation caused by microorganisms such as bacteria, viruses, fungi, and foreign substances that enter the lungs. The therapeutic management of pneumonia is given antibiotics to eliminate the causative bacteria and overall healing. Conceptually, levofloxacin antibiotics are considered better for pneumonia therapy than ceftriaxone. This study aimed to determine the effectiveness of comparing levofloxacin and ceftriaxone antibiotics in pneumonia patients in the inpatient installation of RSD X Cirebon City. Parameters to determine the effectiveness of antibiotics based on body temperature and length of stay (LOS). This study used a retrospective cross-sectional research design. Patient data from medical records were 91 samples that met the inclusion criteria. Data analysis included patient characteristics, antibiotic use, and therapy effectiveness data. Data were tested statistically using Mann-Whitney. The results showed that the comparison of levofloxacin and ceftriaxon had different effectiveness as antibiotic therapy in pneumonia patients hospitalized in RSD X Cirebon City, except based on length of stay.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
Permenkes RI. Pedoman Penggunaan Antibiotik. Permenkes RI 2021:1–97.
Poen A. Evaluasi Penggunaan Antibiotik Pada Pasien Pneumonia di Ruang Instalasi Rawat Inap Rumah Sakit X. Social Clinical Pharmacy Indonesia Journal 2023;7:15–22. https://doi.org/10.52447/scpij.v7i1.6014. DOI: https://doi.org/10.52447/scpij.v7i1.6014
Kementrian Kesehatan, RI. Laporan Nasional Riskesdas. Badan Penelitian dan Pengembangan Kesehatan; 2018.
Dinas Kesehatan. Profil Kesehatan Indonesia. 2021.
Dwi P, Al PP, Bangkalan H. Pengenalan dan Pencegahan Potensi Bakteri Penyebab 2023;4:10846–9.
Perhimpunan Dokter Paru Indonesia (PDPI). Panduan Umum Praktis Klinis Penyakit Paru dan Pernapasan. 2021.
Prasetya AANPR, Wijaya IGEJS, Kurnianta PDM. Evaluasi Penggunaan Antibiotik dengan Metode ATC/DDD dan DU90% pada Pasien Pneumonia di RSD X Tahun 2022. Jurnal Mandala Pharmacon Indonesia 2023;9:408–18. https://doi.org/10.35311/jmpi.v9i2.398. DOI: https://doi.org/10.35311/jmpi.v9i2.398
Khairani S, Ramadaniati HU, Sarnianto P, Kristin E, Anggriani Y. Evaluation of Antibiotic Use with Quantitative Methods in Hospitalization Pneumonia Patients at West Nusa Tenggara Hospital (Evaluasi Penggunaan Antibiotik dengan Metode Kuantitatif pada Pasien Pneumonia Rawat Inap di Rumah Sakit Nusa Tenggara Barat). Jurnal Ilmu Kefarmasian Indonesia 2023;21. DOI: https://doi.org/10.35814/jifi.v21i2.1449
Selvany, Kusumajaya H. Faktor-Faktor yang Berhubungan dengan Kejadian Pneumonia. vol. 1. 2024. https://doi.org/https://doi.org/10.69549/kktc7792.
Faradhila A, Indawati I, Nurhaini R. Evaluasi Penggunaan Antibiotik Yang Rasional Pada Pasien Pneumonia Rawat Inap Di RS X Kota Cirebon. vol. 14. 2023. https://doi.org/https://doi.org/10.61902/cerata.v14i2.815. DOI: https://doi.org/10.61902/cerata.v14i2.815
Rusdy MN, Alfian Jafar M, Maulani D. Faktor Faktor yang Mempengaruhi Kejadian Pneumonia pada Balita di RSUD Haji Kota Makassar 2022. 2024.
Afifah Usri N, Husni A, Darussalam E, Azikin W, Loddo N, Safitri A, et al. Karakteristik Pasien Community Acquired Pneumonia Pada Pasien Balita di Rumah Sakit Ibnu Sina Makassar Tahun 2020-2022 2024;5.
Ilmi T, Yulia R, Herawati F. Evaluasi Penggunaan Antibiotik Pada Pasien Pneumonia di Rumah Sakit Umum Daerah Tulungagung. Jurnal Inovasi Farmasi Indonesia (JAFI) 2020;1:102. https://doi.org/10.30737/jafi.v1i2.903. DOI: https://doi.org/10.30737/jafi.v1i2.903
Kemenkes. Pedoman Nasional Pelayanan Kedokteran Tata Laksana Pneumonia Pada Dewasa. 2023.
Anggita D, Nurisyah S, Wiriansya EP. Mekanisme Kerja Antibiotik: Review Article. UMI Medical Journal 2022;7:46–58. https://doi.org/10.33096/umj.v7i1.149. DOI: https://doi.org/10.33096/umj.v7i1.149
Zahari NIN, Engku Abd Rahman ENS, Irekeola AA, Ahmed N, Rabaan AA, Alotaibi J, et al. A Review of the Resistance Mechanisms for β-Lactams, Macrolides and Fluoroquinolones among Streptococcus pneumoniae. Medicina (Lithuania) 2023;59. https://doi.org/10.3390/medicina59111927. DOI: https://doi.org/10.3390/medicina59111927
Meriyani H, Udayani NNW. Perbandingan Penggunaan Antibiotik Tunggal dan Kombinasi Pada Pasien Pediatrik dengan Gastroenteritis Akut (GEA) di RSUD Wangaya Denpasar. Jurnal Ilmiah Medicamento 2018;4. https://doi.org/10.36733/medicamento.v4i1.882. DOI: https://doi.org/10.36733/medicamento.v4i1.882
Yang R, Li Y, Li J, Xing L, Liu L. Clinical efficacy of ceftazidime combined with levofloxacin on heart failure complicated with pulmonary infection and its influence on cardiopulmonary function. vol. 13. 2021.
Damayanti M, Olivianto E, Yunita EP. Effects of Rational Use of Antibiotics on Clinical Improvement of Pediatric Inpatients with Pneumonia. Indonesian Journal of Clinical Pharmacy 2022;11:129–44. https://doi.org/10.15416/ijcp.2022.11.2.129. DOI: https://doi.org/10.15416/ijcp.2022.11.2.129
Rahardjoputro R, Sholihah I, Amrullah AW. Ketepatan Pemilihan Peresepan Antibiotik untuk Terapi Pneumonia pada Pasien Lansia Rawat Inap di Rumah Sakit X Surakarta. Indonesian Journal of Pharmacy and Natural Product 2023;6:1–7. https://doi.org/10.35473/ijpnp.v6i01.2152. DOI: https://doi.org/10.35473/ijpnp.v6i01.2152
Yadegarynia D, Tehrani S, Nejad FM, Shojaeian F, Keyvanfar A. Levofloxacin versus ceftriaxone and azithromycin for treating community-acquired pneumonia: a randomized clinical trial study. vol. 14. 2022. DOI: https://doi.org/10.18502/ijm.v14i4.10231